AJMC Staff

FDA staff are not convinced that the smoking-cessation drugs varenicline (Chantix), developed by Pfizer, and bupropion (Zyban), developed by GSK, do not increase suicidal tendencies among users.

What we're reading, September 12, 2016: Hillary Clinton's health is being called into question as her campaign confirms she has pneumonia; responders who helped during the 9/11 terrorist attacks may be sick and not know it; and Sanofi and Google team up for a diabetes venture.

Highlights of our peer-reviewed research in the healthcare press.

What we're reading, September 9, 2016: Walgreens believes it may need to unload more stores to ease antitrust concerns over its Rite Aid purchase; the Senate may be nearing a Zika funding agreement; and American dissatisfaction with their healthcare system.

What we're reading, September 8, 2016: An Arizona county at risk of having no Affordable Care Act plans in 2017 gains an insurer; the difficulty of obtaining medical records; and Ohio county offers immunity for anyone turning in deadly drugs.

What we're reading, September 7, 2016: Allergan vows to limit drug price hikes; Senate votes again to block Zika funding bill; and CMS will institute a new process to screen people signing up for Obamacare coverage during special enrollment periods.

What we're reading, September 6, 2016: state prescription databases play a role in fighting the opioid epidemic; experimenting with transition models to reduce gaps in care; and how electronic health records slow down doctors.

What we're reading, September 5, 2016: Zika virus remains a global health emergency and worsens in Asia; the government provides "simple choice plan" options for 2017's open enrollment season; and how hospitals are improving the workplace.

Highlights of our peer-reviewed research in the healthcare and maintstream press.

What we're reading, September 2, 2016: California taxpayers will cover 70% of the state's healthcare costs in 2016; President Barack Obama supports recommendations to reform the Veterans Affairs healthcare system; and California is close to criminalizing undercover stings against Planned Parenthood.

What we're reading, August 31, 2016: 51% of Americans have a negative view of the pharmaceutical industry; the CDC is running out of funds to fight the Zika virus; and Pennsylvania chooses 3 private companies to manage Medicaid plans.

What We're Reading, August 30, 2016: the Justice Department is investigating police treatment of the mentally ill; researchers identify overtreatment based on imaging procedures; and 2 drug compounds may prevent the Zika virus from replicating in the body.

What we're reading, August 29, 2016: Audit finds Medicare Advantage plans overcharged the government; enrollment on the Affordable Care Act's exchanges less than half of initial prediction; and California bill to protect consumers from surprise medical bills divides physicians.

A review of our peer-reviewed research, in the healthcare and mainstream press.

What we're reading, August 26, 2016: the middle class is burdened with increasing healthcare costs; how much do voters need to know about presidential candidates' health; and honoring the end-of-life wishes of patients with dementia.

What we're reading, August 25, 2016: Hillary Clinton proposes fund for public health crises; hospitals that treated victims of the Orlando Pulse nightclub shooting will not bill survivors; and 1 in 4 people admit to using leftover antibiotics.

What we're reading, August 24, 2016: Tennessee signed off on high premium hikes as its exchange is close to collapse; 5 states sue the Obama administration over a transgender healthcare policy; and a new non—travel-related Zika case is identified in Tampa Bay.

What we're reading, August 23, 2016: Republicans in Congress indicate they may be willing to fix the Affordable Care Act instead of repeal it once President Obama is out of office; an Alzheimer's drug receives fast-track designation from the FDA; and Pfizer to acquire Medivation.

What we're reading, August 22, 2016: freestanding emergency clinics come under increased scrutiny; hospitals are being more open about medical mistakes; and regulations to blame for rising generic drug prices.

What we're reading, August 19, 2016: CMS is investigating if patients are being steered away from Medicaid and Medicare to private plans; Medicare Part D paid 17% more for drugs in 2014 than in 2013; and 5 things to know about HIPAA today.

A review of coverage of our peer-reviewed research, in the mainstream and healthcare press.

What we're reading, August 18, 2016: California drug price transparency bill gets pulled; researchers work on a new opioid painkiller without the addiction; and the need for more diversity in genetic sequencing.

What we're reading, August 16, 2016: hospitals are partnering with ride-hailing services to get patients to their appointments; Democrats look to repeal a ban on federal funding for abortion; and Colorado will vote on a right-to-die bill this fall.

What we're reading, August 15, 2016: public health emergency declared in Puerto Rico over Zika virus; the number of local transmission infections of Zika continues to climb in Florida; and men more likely to rate their health as excellent or good compared to 2007.

A review of our peer-reviewed research featured in the healthcare and mainstream press.

What we're reading, August 12, 2016: CMS announces Obamacare plans saw a healthier mix of consumers last year; the number of babies born addicted to opioids tripled in 15 years; and the Obama administration will shift funding from HHS to fight Zika.

What we're reading, August 11, 2016: hospitals are throwing out less-than-perfect organs and refusing transplants; why an increasing reliance on hospitalists is bad for comprehensive care; and removing the roadbloack to marijuana research.

What we're reading, August 10, 2016: mortality rate in the United States declines after 2015's increase; infant death in Texas linked to Zika virus; and Ohio colleges drop student health insurance due to Obamacare provisions.

What we're reading, August 9, 2016: tying drug costs to outcomes is the future of drug pricing; Walgreens expands drug take-back kiosk program; patients with atrial fibrillation need to consult a second doctor before receiving a new medical device.

While the online tools makes clear consumers can use it without obligation, the therapy section give patients information on AstraZeneca products.